© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
A year into the pandemic, the FDA, CDC and USDA say there’s no credible evidence linking food or packaging to COVID-19.
The public can watch the proceedings on the FDA website and the agency’s YouTube, Facebook and Twitter channels.
In the search for solutions to her uterine fibroids symptoms, New Jerseyan Lorraine Abudeye has learned to question what care providers say.
David Kessler will helm Operation Warp Speed as AIDS activists urge the United States to supply the world with COVID-19 vaccines.
Pfizer/BioNTech’s coronavirus vaccine is 95% effective for preventing symptomatic illness.
In the United States, an FDA expert advisory panel voted on December 10 to recommend emergency use authorization.
With the first vaccines expected within weeks, a CDC advisory panel votes on how to prioritize access.
Moderna has requested emergency use authorization for its mRNA vaccine candidate.
Agency grants emergency authorization for antibody cocktail given to President Trump.
Upcoming hearing on the Pfizer/BioNTech vaccine will be livestreamed on YouTube, Facebook and Twitter.
Arthritis drug Olumiant (baricitinib) can be used in combination with remdesivir.
The new test kit, available by prescription, uses a self-collected nasal swab sample.
A study analyzed how well people with HIV and their health care providers can navigate the experimental long-acting injectable Cabenuva.
The panel’s goal is to ensure that all coronavirus therapeutics approved by the government are safe and effective for African Americans.
Plasma from recovered patients recently received a controversial FDA emergency use authorization as a potential treatment for COVID-19.
“The SalivaDirect test...is yet another testing innovation game changer that will reduce the demand for scarce testing resources.”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.